Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 10 December 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-131-3
7440-22-4
2014
Netherlands
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
231-511-9
7601-89-0
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
Wide dispersive use
Concluded
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
204-825-9
127-18-4
2013
Latvia
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-286-2
137-26-8
2014
Sweden
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-800-2
126-73-8
2012
Hungary
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-944-3
7779-90-0
2013
Romania
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-425-9
95-50-1
2013
Hungary
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
2013
Denmark
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Conclusion under preparation
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Conclusion under preparation
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Conclusion under preparation
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Conclusion under preparation
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
211-745-8
693-21-0
2016
Italy
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
High RCR
Conclusion under preparation
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
412-780-3
-
France
Suspected PBT/vPvB
Conclusion under preparation
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Follow-up
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
219-785-8
2530-85-0
2015
Ireland
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
202-859-9
100-51-6
2016
Germany
Suspected Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Follow-up
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Follow-up
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
205-491-7
141-62-8
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Follow-up
Details
234-042-8
10508-09-5
2015
Italy
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
Wide dispersive use
Follow-up
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
211-063-0
628-96-6
2016
Italy
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Follow-up
Details
203-497-4
107-51-7
2015
Norway
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Follow-up
Details
228-250-8
6197-30-4
2012
France
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Follow-up
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
210-382-2
614-45-9
2013
Italy
Sensitiser
Consumer use
Wide dispersive use
Follow-up
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
246-677-8
25155-23-1
2014
Italy
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Follow-up
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
271-082-5
68515-40-2
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Information requested
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Information requested
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1